US4599318A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Tissue protein PP19, a process for obtaining it, and its use
Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1985-02-07
•
Granted: 1986-07-08
•
Expires: 2005-02-07
Abstract
Abstract The protein PP19 which has (a) an electrophoretic mobility in the region between that of alpha 1 and of beta 1 globulins; (b) an isoelectric point between 4.6 and 5.4; (c) a sedimentation coefficient s20,w of 3.25+/-0.25 S; (d) a molecular weight determined in the ultracentrifuge of 36,500+/-4,000; (e) a carbohydrate fraction of 3.9+/-1.5 g/100 g (mannose 0.3+/-0.2, fucose 0.2+/-0.1, galactose 1.0+/-0.3, glucose 0.4+/-0.2, N-acetylglucosamine 1.2+/-0.3, N-acetylgalactosamine 0.1+/-0.1, and N-acetylneuraminic acid 0.7+/-0.3, each g/100 g); and (f) a particular amino acid composition, is described, as is a process for obtaining it.
Inventors
- 👤 Hans Bohn
- 👤 Wilhelm Winckler
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 05:59
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/46; C07K14/47; C07K14/4701; C07K14/4715; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/68; G01N33/689; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/806
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
168 words
A protein PP 19 extracted from a source of said protein and having the following characteristics: (a) an electrophoretic mobility in the region between that of α 1 and of β 1 globulins; (b) an isoelectric point between 4.6 and 5.4; (c) a sedimentation coefficient s 20 ,w of 3.25±0.25 S; (d) a molecular weight determined in the ultracentrifuge of 36,500±4,000; (e) a carbohydrate fraction of 3.9±1.5 g/100 g (mannose 0.3±0.2, fucose 0.2±0.1, galactose 1.0±0.3, glucose 0.4±0.2, N-acetylglucosamine 1.2±0.3, N-acetylgalactosamine 0.1±0.1, and N-acetylneuraminic acid 0.7±0.3, each g/100 g); and (f) an amino acid composition as in the following table: ______________________________________
Residues per
Coefficient of
Amino acid 100 residues
variation
______________________________________
lysine 8.63 2.92
histidine 1.71 14.20
arginine 2.73 7.71
aspartic acid 11.51 3.99
threonine 4.20 15.75
serine 7.48 2.26
glutamic acid 11.09 3.20
proline 4.12 18.29
glycine 6.88 5.12
alanine 7.56 3.30
cystine 1/2 2.10 22.58
valine 7.44 3.98
methionine 2.39 7.24
isoleucine 3.40 6.38
leucine 10.03 7.29
tyrosine 2.19 2.96
phenylalanine 5.05 2.58
tryptophan 1.42 15.43
______________________________________
Claim 2
Dependent Claim
168 words
A protein PP 19 extracted from a source of said protein and having the following characteristics: (a) an electrophoretic mobility in the region between that of α 1 and of β 1 globulins; (b) an isoelectric point between 4.6 and 5.4; (c) a sedimentation coefficient s 20 ,w of 3.25±0.25 S; (d) a molecular weight determined in the ultracentrifuge of 36,500±4,000; (e) a carbohydrate fraction of 3.9±1.5 g/100 g (mannose 0.3±0.2, fucose 0.2±0.1, galactose 1.0±0.3, glucose 0.4±0.2, N-acetylglucosamine 1.2±0.3, N-acetylgalactosamine 0.1±0.1, and N-acetylneuraminic acid 0.7±0.3, each g/100 g); and (f) an amino acid composition as in the following table: ______________________________________
Residues per
Coefficient of
Amino acid 100 residues
variation
______________________________________
lysine 8.63 2.92
histidine 1.71 14.20
arginine 2.73 7.71
aspartic acid 11.51 3.99
threonine 4.20 15.75
serine 7.48 2.26
glutamic acid 11.09 3.20
proline 4.12 18.29
glycine 6.88 5.12
alanine 7.56 3.30
cystine 1/2 2.10 22.58
valine 7.44 3.98
methionine 2.39 7.24
isoleucine 3.40 6.38
leucine 10.03 7.29
tyrosine 2.19 2.96
phenylalanine 5.05 2.58
tryptophan 1.42 15.43
______________________________________
Claim 3
Dependent Claim
194 words
A process for obtaining or enriching PP 19 as claimed in claim 1, which comprises subjecting an extract which has been obtained, using a dilute salt or buffer solution or a solution of a solubilizing agent, from at least one organ which contains this protein PP 19 to one or more of the following measures: (a) Precipitation of the protein PP 19 with ammonium sulfate in the pH range of 5 to 8 and at 30-70% saturation; (b) Precipitation of the protein PP 19 using a water-soluble acridine base at a pH of 8 to 9 and a concentration of the base of 4-8 g/l; (c) Separation out of part of the accompanying proteins by addition of ethanol at pH 7 up to a final concentration of 200 ml/l alcohol; (d) Preparative zone electrophoresis, where the protein fraction between α 1 and β 2 globulins is obtained; (e) Gel filtration or ultrafiltration where proteins in the molecular weight range of 20,000 to 60,000 are obtained; (f) Adsorption onto a weakly basic ion exchanger and elution of the protein PP 19 ; and (g) Enrichment by immunoadsorption, to obtain or enrich said PP 19 protein.
Claim 4
Dependent Claim
37 words
The process of claim 2, wherein said organ is selected from the group consisting of placenta, stomach and spleen, wherein said buffer solution is a glycine HCl buffer and wherein said solubilizing agent is a urea solution.
Claim 5
Dependent Claim
45 words
A process for isolating the protein PP 19 of claim 1 comprising the steps of subjecting a liquid containing said protein PP 19 to at least one known procedure for isolating proteins and, in each instance, recovering that material containing said protein PP 19 .
Claim 6
Dependent Claim
20 words
The protein PP 19 of claim 1, said protein being extracted from an organ or an extract of an organ.
Claim 7
Dependent Claim
20 words
The protein PP 19 of claim 5, said protein being extracted from a placenta or an extract of a placenta.
Claim 8
Dependent Claim
12 words
The protein PP 19 of claim 6, said protein being substantially pure.
Claim 9
Dependent Claim
24 words
An antiserum to the protein PP 19 of claim 1 obtained by immunizing an animal with said protein PP 19 and recovering said antiserum.
Claim 10
Dependent Claim
23 words
A method for detecting and determining protein PP 19 comprising the step of utilizing an effective amount of the antiserum of claim 8.
Claim 11
Dependent Claim
159 words
A substantially pure protein PP 19 , with the following characteristics: (a) an electrophoretic mobility in the region between that of α 1 and of β 1 globulins; (b) an isoelectric point between 4.6 and 5.4; (c) a sedimentation coefficient s 20 ,w of 3.25±0.25 S; (d) a molecular weight determined in the ultracentrifuge of 36,500±4,000; (e) a carbohydrate fraction of 3.9±1.5 g/100 g (mannose 0.3±0.2, fucose 0.2±0.1, galactose 1.0±0.3, N-acetylglucosamine 1.2±0.3, and N-acetylneuraminic acid 0.7±0.3, each g/100 g); and (f) an amino acid composition as in the following table: ______________________________________
Residues per
Coefficient of
Amino acid 100 residues
variation
______________________________________
lysine 8.63 2.92
histidine 1.71 14.20
arginine 2.73 7.71
aspartic acid 11.51 3.99
threonine 4.20 15.75
serine 7.48 2.26
glutamic acid 11.09 3.20
proline 4.12 18.29
glycine 6.88 5.12
alanine 7.56 3.30
cystine 1/2 2.10 22.58
valine 7.44 3.98
methionine 2.39 7.24
isoleucine 3.40 6.38
leucine 10.03 7.29
tyrosine 2.19 2.96
phenylalanine 5.05 2.58
tryptophan 1.42 15.43
______________________________________
Claim 12
Dependent Claim
159 words
A substantially pure protein PP 19 , with the following characteristics: (a) an electrophoretic mobility in the region between that of α 1 and of β 1 globulins; (b) an isoelectric point between 4.6 and 5.4; (c) a sedimentation coefficient s 20 ,w of 3.25±0.25 S; (d) a molecular weight determined in the ultracentrifuge of 36,500±4,000; (e) a carbohydrate fraction of 3.9±1.5 g/100 g (mannose 0.3±0.2, fucose 0.2±0.1, galactose 1.0±0.3, N-acetylglucosamine 1.2±0.3, and N-acetylneuraminic acid 0.7±0.3, each g/100 g); and (f) an amino acid composition as in the following table: ______________________________________
Residues per
Coefficient of
Amino acid 100 residues
variation
______________________________________
lysine 8.63 2.92
histidine 1.71 14.20
arginine 2.73 7.71
aspartic acid 11.51 3.99
threonine 4.20 15.75
serine 7.48 2.26
glutamic acid 11.09 3.20
proline 4.12 18.29
glycine 6.88 5.12
alanine 7.56 3.30
cystine 1/2 2.10 22.58
valine 7.44 3.98
methionine 2.39 7.24
isoleucine 3.40 6.38
leucine 10.03 7.29
tyrosine 2.19 2.96
phenylalanine 5.05 2.58
tryptophan 1.42 15.43
______________________________________
Claim 13
Dependent Claim
56 words
A method of diagnosing or monitoring a disease or monitoring the treatment of said disease, said disease being accompanied by an increase in the concentration of protein PP 19 , comprising the step of utilizing in an immunochemical method the protein PP 19 of claim 1 to achieve said intended purpose with respect to said disease.
References Cited (Backward Citations)
US4254021A
Cited
US4301064A
Cited
US4302385A
Cited
US4325866A
Cited
US4368148A
Cited
US4468345A
Cited
US4500451A
Cited
US4507229A
Cited
US4524027A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-07-07 | 1990-01-06 | 1990-07-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-07-07 | 1994-01-06 | 1994-07-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-07-07 | 1998-01-06 | 1998-07-08 | $7700.00 | Window Closed / Lapsed |